U.S. Markets closed

Voyager Therapeutics stock jumps on 2nd Parkinson's deal

Allison DeAngelis
Voyager Therapeutics stock jumps on 2nd Parkinson's deal

Voyager (Nasdaq: VYGR) is expanding its partnership with pharmaceutical company AbbVie (Nasdaq: ABBV), launching a research effort to develop antibody treatments that can be delivered directly to the brain and target a protein called alpha-synuclein.